Bilash Kuila

Title: Bilash Kuila: Innovator in Therapeutic Compounds

Introduction

Bilash Kuila is a notable inventor based in Howrah, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of therapeutic compounds. His work focuses on creating innovative solutions for diseases that depend on specific biological pathways.

Latest Patents

Bilash Kuila holds a patent for "6-substituted pyridazine compounds as SMARCA2 and/or SMARCA4 degraders." This invention provides 6-substituted pyridazine compounds of formula (I) that are therapeutically useful as SMARCA2 and/or SMARCA4 degraders. These compounds are designed to be effective in treating and/or delaying the progression of diseases or disorders that are dependent upon SMARCA2 and/or SMARCA4 in a subject. The patent also details the preparation of these compounds and pharmaceutical compositions that include at least one of the compounds of formula (I) or a pharmaceutically acceptable salt, stereoisomer, tautomer, or prodrug thereof. He has 1 patent to his name.

Career Highlights

Bilash Kuila is currently associated with Aurigene Oncology Limited, where he continues to advance his research in oncology and therapeutic development. His work is pivotal in the quest for new treatments that can improve patient outcomes in cancer care.

Collaborations

He collaborates with talented professionals in his field, including Chandrasekhar Abbineni and Susanta Samajdar. These collaborations enhance the innovative potential of his research and contribute to the development of effective therapeutic solutions.

Conclusion

Bilash Kuila is a dedicated inventor whose work in developing SMARCA2 and/or SMARCA4 degraders represents a significant advancement in therapeutic compounds. His contributions to the field of medicinal chemistry are noteworthy and have the potential to impact the treatment of various diseases.